Clinical trials
Recruiting Tuberculosis, Multidrug-Resistant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| University of California, San Francisco | 2 |
| Albert Einstein College of Medicine | 1 |
| Columbia University | 1 |
| Foundation for Innovative New Diagnostics, Switzerland | 1 |
| Huashan Hospital | 1 |
| Institute of Tropical Medicine, Belgium | 1 |
| Johns Hopkins University | 1 |
| Marco Schiuma | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Multidrug-Resistant | 15 |
| Tuberculosis | 6 |
| Tuberculosis, Pulmonary | 3 |
| HIV Infections | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Extensively Drug-Resistant Tuberculosis | 1 |
| Latent Tuberculosis | 1 |
| Mycobacterium Infections | 1 |
| Peripheral Nervous System Diseases | 1 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.